PMID- 24372954 OWN - NLM STAT- MEDLINE DCOM- 20150618 LR - 20191210 IS - 1360-0443 (Electronic) IS - 0965-2140 (Linking) VI - 109 IP - 5 DP - 2014 May TI - Use of Silk Road, the online drug marketplace, in the United Kingdom, Australia and the United States. PG - 774-83 LID - 10.1111/add.12470 [doi] AB - AIMS: To investigate the prevalence of awareness of the online illicit drug marketplace Silk Road (SR), consumption of drugs purchased from SR and reasons for use and non-use of SR. DESIGN AND SETTING: Global Drug Survey: purposive sample collected in late 2012. PARTICIPANTS: The base sample (n = 9470) reported recent drug purchase and resided in the United Kingdom (n = 4315, median age 24, 76% male), Australia (n = 2761, median age 32, 76% male) or the United States (n = 2394, median age 21, 80% male). MEASUREMENTS: Online questionnaire. FINDINGS: A total of 65% of US, 53% of Australian and 40% of UK respondents had heard of SR; 18% of US, 10% of UK and 7% of Australian respondents had consumed drugs purchased through SR. Across the three countries, 3,4-methylenedioxy-N-methylamphetamine (MDMA) was the most commonly purchased drug (53-60%), followed by cannabis (34-51%), lysergic acid diethylamide (LSD) (29-45%) and the 2C family (16%-27%). The most common reasons for purchasing from SR were wider range (75-89%), better quality (72-77%), greater convenience (67-69%) and the use of vendor rating systems (60-65%). The most common reasons for avoiding SR purchase were adequate drug access (63-68%) and fear of being caught (41-53%). Logistic regressions found that, compared with people from the UK, Australians [odds ratio (OR) = 3.37; 95% confidence interval (CI) = 2.29, 4.97) and Americans (OR = 1.46; 95% CI = 1.10, 1.94) were more likely to use SR due to lower prices; and to avoid SR purchase due to fear of being caught (Australia: OR = 1.65; 95% CI = 1.39, 1.96; USA: OR = 1.62; 95% CI = 1.37, 1.92). CONCLUSIONS: While reasons for Silk Road use accord with broader online commerce trends (range, quality, convenience, ratings), its appeal to drug purchasers is moderated by country-specific deterrents and market characteristics. CI - (c) 2013 Society for the Study of Addiction. FAU - Barratt, Monica J AU - Barratt MJ AD - National Drug Research Institute, Curtin University, Fitzroy, Victoria, Australia. FAU - Ferris, Jason A AU - Ferris JA FAU - Winstock, Adam R AU - Winstock AR LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140212 PL - England TA - Addiction JT - Addiction (Abingdon, England) JID - 9304118 RN - 0 (Illicit Drugs) RN - 8NA5SWF92O (Lysergic Acid Diethylamide) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM CIN - Addiction. 2014 May;109(5):784-5. PMID: 24720826 MH - Adult MH - Australia MH - Cannabis MH - Data Collection MH - Drug Trafficking/*statistics & numerical data MH - Female MH - Humans MH - *Illicit Drugs MH - Internet/*statistics & numerical data MH - Logistic Models MH - Lysergic Acid Diethylamide MH - Male MH - N-Methyl-3,4-methylenedioxyamphetamine MH - United Kingdom MH - United States MH - Young Adult OTO - NOTNLM OT - Cryptomarket OT - Silk Road OT - drug market OT - internet OT - new drug trends OT - online marketplace EDAT- 2014/01/01 06:00 MHDA- 2015/06/19 06:00 CRDT- 2013/12/31 06:00 PHST- 2013/06/27 00:00 [received] PHST- 2013/09/01 00:00 [revised] PHST- 2013/12/16 00:00 [accepted] PHST- 2013/12/31 06:00 [entrez] PHST- 2014/01/01 06:00 [pubmed] PHST- 2015/06/19 06:00 [medline] AID - 10.1111/add.12470 [doi] PST - ppublish SO - Addiction. 2014 May;109(5):774-83. doi: 10.1111/add.12470. Epub 2014 Feb 12.